Patent · US Active

Boronic acid derivatives

US10640520B2 · kind B2 · utility

2Cited by

1References

12Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Markus Klein · Weiterstadt, DE
Oliver Schadt · Rodenbach, DE
Philipp Haselmayer · Wiesbaden, DE
Michael Busch · Darmstadt, DE

Key dates

Filing date	Oct 1, 2015
Grant date	May 5, 2020
Priority date	—
Expiry date	Oct 1, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.